Targeting selected emerging markets

Emerging markets in general have proved a disappointment for many investors this year – and indeed over the longer term. However, we believe there are opportunities to be found in economies such as Brazil, Indonesia and Mexico. All three benefit from a strong economic backdrop and are home to well-managed companies with good growth prospects.

Emerging markets (EM) have long been touted as offering significant growth opportunities for investors. Yet, as a whole, EM equities have disappointed. The MSCI EM index, for example, is up by just 0.7% in local terms over the year to date, compared with a 9.6% rise in the MSCI World Index. The strong dollar and weakness in China’s economy are among the factors weighing on EM stocks this year.

That’s why we believe investors should take a highly targeted approach to the region. We are building confidence in economies like Indonesia, Brazil and Mexico where valuations are attractive and economic fundamentals are improving. Central banks have controlled inflation and now have scope to cut rates. Take the example of Brazil, where the annual pace of inflation fell more than expected in October. The central bank cut interest rates in August – having hiked them to a six-year high – and has pledged to implement further cuts in the months ahead.

Brazil’s sensible approach to fiscal spending (targeting a primary surplus in 2025 – the first since 2013) and tax reform provide further encouragement. Economic growth is also picking up, assisted by high commodity prices such as iron ore and soybeans.

Indonesia, meanwhile, posted solid growth of 4.9% in the third quarter, with robust private consumption (which accounts for more than half of Indonesia’s GDP) helping to offset falling exports as global growth slows. Indonesia is much less dependent on global growth than its regional counterparts: exports account for 20% of GDP, compared with 60% for Thailand. Higher government spending in the run-up to the 2024 general election should support economic activity during the fourth quarter. In the long term, the country will benefit from plentiful natural resources, a large and youthful working population, and a growing middle class. A robust banking system and strong public finances are other positives.

The Mexican economy is another bright spot globally. The International Monetary Fund, ratings agencies and investment banks have all upgraded their growth forecasts. Robust investment, the completion of unfinished projects and “friend-shoring” are among the key drivers supporting economic activity.

Investment opportunities in these markets include Fomento Económico Mexicano (FEMSA), the dominant convenience store chain in Mexico. The company is attractively priced, has excellent growth prospects – it reported consensus-beating third-quarter earnings at the end of October – with an opportunity to take market share from mom and pop operators.

Read our Q3 Market Update to learn more about the opportunities we see in emerging markets. You can also learn more about investing in emerging markets in this episode of the Good Value podcast.

Subscribe to receive the latest news and insights from Antipodes

 


IMPORTANT INFORMATION:
All content in respect of the Antipodes Global Shares (Quoted Managed Fund) (ARSN 625 560 269), the Antipodes Global Fund – Long (ARSN 118 075 764), the Antipodes Global Fund (ARSN 087 719 515), and the Antipodes Emerging Markets (Managed Fund) (ARSN 096 451 393) is issued by Pinnacle Fund Services Limited ABN 29 082 494 371 AFSL 238 371 (“PFSL”) as responsible entity of the Funds and is prepared by Antipodes Partners Limited (ABN 29 602 042 035) (AFSL 481580) (“Antipodes”) as the investment manager of the Trust. PFSL is not licensed to provide financial product advice.
The information provided is of a general nature only and has been prepared without taking into account your objectives, financial situation or needs. Before making an investment decision in respect of the Funds, you should consider the current Product Disclosure Statement (‘PDS’) and Target Market Determination (‘TMD’) of the Funds and the Fund’s other periodic and continuous disclosure announcements lodged with the ASX, which are available at www.asx.com.au, and assess whether the Fund is appropriate given your objectives, financial situation or needs. If you require advice that takes into account your personal circumstances, you should consult a licensed or authorised financial adviser. The Product Disclosure Statement (‘PDS’) and Target Market Determination (‘TMD’) of the relevant Fund are available via below links. Any potential investor should consider the PDS and TMD before deciding whether to acquire, or continue to hold units in, the Fund.
Links to Product Disclosure Statement: IOF0045AU, WHT0057AU, IOF0203AUWHT3997AU
Links to Target Market Determination: IOF0045AU, WHT0057AU, IOF0203AUWHT3997AU
For historic TMD’s please contact Pinnacle client service Phone 1300 010 311 or Email service@pinnacleinvestment.com
Neither PFSL nor Antipodes guarantees repayment of capital or any particular rate of return from the Funds. Neither PFSL nor Antipodes gives any representation or warranty as to the currency, reliability, completeness or accuracy of the information contained in this content. All opinions and estimates included in this website constitute judgments of Antipodes as at the date of website creation and are subject to change without notice. Past performance is not a reliable indicator of future performance.

4 December 2023
By Alison Savas By Alison Savas 3 min 3 min